SenoRx to Present At Canaccord Adams Global Growth Conference
July 26, 2007 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., July 26, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the Canaccord Adams Global...
SenoRx Announces Second Quarter 2007 Financial Results Conference Call
July 16, 2007 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., July 16, 2007 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its second quarter financial results on Tuesday, August 14, 2007 following the market...
SenoRx Announces First Uses of Its Multi-Lumen Radiation Balloon; Company Records First Commercial Sales of New Product
June 28, 2007 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., June 28, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced the first procedures using its new Multi-Lumen Radiation Balloon at two clinical sites. SenoRx...
SenoRx CEO to be Interviewed Live On MN1, On Friday, June 22, At 11:00 A.M. ET
June 21, 2007 10:30 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., June 21, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced today that its President and CEO, Lloyd Malchow, will be featured in an exclusive live interview to be...
SenoRx Announces Additional Patent Granted for Radiation Balloon
June 18, 2007 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., June 18, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that the United States Patent and Trademark Office has granted the company its third patent related to...
SenoRx Named Outstanding Medical Device Company by AeA Orange County and Inland Empire Council
May 29, 2007 09:30 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 29, 2007 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO), a medical device company focused on the development, manufacture and sale of an expanding range of products used to diagnose...
SenoRx Announces 510(k) Clearance for Its Multi-Lumen Radiation Balloon
May 23, 2007 09:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 23, 2007 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its...
SenoRx Reports Strong First Quarter 2007 Results
May 15, 2007 16:05 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 15, 2007 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO) today reported financial results for its first quarter ended March 31, 2007. Revenue for the quarter increased 32 percent to...
SenoRx Appoints New Director
May 14, 2007 10:00 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 14, 2007 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced the appointment of Vickie Capps to its board of directors, effective June 14, 2007. Ms. Capps currently...
SenoRx Announces Participation in Upcoming Investor Conferences
May 08, 2007 12:44 ET
|
SenoRx, Inc.
ALISO VIEJO, Calif., May 8, 2007 (PRIME NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will be presenting at the following conferences:...